Pradelli, L. (2014) “The economic impact associated with cerebrovascular events related to non-valvular atrial fibrillation (NVAF) in Italy: the role of apixaban”, Farmeconomia. Health economics and therapeutic pathways, 15(1S), pp. 3–4. doi: 10.7175/fe.v15i1s.972.